SYM FINANCIAL Corp Acquires 179 Shares of Cigna Group $CI

SYM FINANCIAL Corp lifted its stake in Cigna Group (NYSE:CIFree Report) by 21.9% during the 2nd quarter, Holdings Channel reports. The firm owned 998 shares of the health services provider’s stock after acquiring an additional 179 shares during the period. SYM FINANCIAL Corp’s holdings in Cigna Group were worth $330,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in CI. Valeo Financial Advisors LLC boosted its holdings in Cigna Group by 86,071.1% during the second quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock worth $1,148,859,000 after buying an additional 3,471,249 shares during the last quarter. Nuveen LLC acquired a new stake in shares of Cigna Group in the 1st quarter valued at approximately $727,905,000. Price T Rowe Associates Inc. MD boosted its stake in Cigna Group by 10.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock worth $3,966,690,000 after acquiring an additional 1,094,327 shares during the last quarter. GQG Partners LLC grew its holdings in Cigna Group by 21.5% during the first quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock valued at $1,607,716,000 after purchasing an additional 865,092 shares during the period. Finally, Goldman Sachs Group Inc. increased its stake in Cigna Group by 38.3% in the first quarter. Goldman Sachs Group Inc. now owns 1,649,837 shares of the health services provider’s stock valued at $542,796,000 after purchasing an additional 457,052 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

Insider Buying and Selling

In related news, insider Brian C. Evanko sold 5,368 shares of Cigna Group stock in a transaction dated Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the sale, the insider owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. The trade was a 9.49% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the completion of the sale, the insider directly owned 25,648 shares in the company, valued at approximately $7,694,400. This represents a 52.66% decrease in their position. The disclosure for this sale can be found here. 0.70% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the stock. Wall Street Zen cut shares of Cigna Group from a “buy” rating to a “hold” rating in a research report on Friday, October 3rd. Robert W. Baird set a $372.00 target price on Cigna Group in a report on Thursday, August 14th. Cantor Fitzgerald reissued an “overweight” rating and issued a $365.00 target price on shares of Cigna Group in a research note on Tuesday, August 26th. Wells Fargo & Company raised their price target on Cigna Group from $340.00 to $354.00 and gave the stock an “equal weight” rating in a research report on Tuesday, October 7th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Cigna Group in a research report on Wednesday, October 8th. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $369.89.

Check Out Our Latest Report on CI

Cigna Group Price Performance

Shares of CI opened at $309.61 on Tuesday. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. The stock has a 50 day simple moving average of $299.43 and a 200 day simple moving average of $307.46. Cigna Group has a 52-week low of $256.89 and a 52-week high of $350.00. The firm has a market capitalization of $82.64 billion, a PE ratio of 16.90, a P/E/G ratio of 0.88 and a beta of 0.45.

Cigna Group (NYSE:CIGet Free Report) last released its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, topping analysts’ consensus estimates of $7.15 by $0.05. The firm had revenue of $67.13 billion during the quarter, compared to the consensus estimate of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The business’s revenue was up 11.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Sell-side analysts predict that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be issued a $1.51 dividend. The ex-dividend date is Thursday, December 4th. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.0%. Cigna Group’s dividend payout ratio (DPR) is 32.97%.

Cigna Group Company Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Read More

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.